Johnson & Johnson booster slashes risk of Omicron hospitalisation, study shows
Two doses cut likelihood by up to 85% according to real-world South African research
Full Article
Johnson & Johnson booster slashes risk of Omicron hospitalisation, study shows
FT.com
0 shares
1 views
You might like
Related news coverage
Qatar - J&J Covid booster highly effective against severe Omicron: study
(MENAFN - Gulf Times) A preliminary South African government study published yesterday showed a booster of the Johnson & Johnson..
MENAFN.com